HomeECX • FRA
add
Epigenomics AG
Previous close
€1.50
Day range
€1.31 - €1.31
Year range
€0.50 - €2.55
Market cap
912.30K EUR
Avg Volume
1.13K
P/E ratio
-
Dividend yield
-
Primary exchange
FRA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 83.50K | 281.52% |
Net income | -398.00K | 84.88% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 57.25K | -91.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.21M | -66.32% |
Total assets | 12.04M | 185.46% |
Total liabilities | 20.38M | 783.10% |
Total equity | -8.34M | — |
Shares outstanding | 875.15K | — |
Price to book | -0.16 | — |
Return on assets | -1.73% | — |
Return on capital | -6.78% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -398.00K | 84.88% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Epigenomics AG is a molecular diagnostics company headquartered in Berlin, Germany with a wholly owned subsidiary, Epigenomics Inc. based in Seattle, WA. Wikipedia
Founded
1998
Headquarters
Website
Employees
6
